Journal Reviews

Predicting which oropharyngeal SCC HPV-positive patients should avoid de-escalated treatment

1 July 2017 | | cetuximab, cisplatin, oropharyngeal cancer, radiotherapy, Smoking

This study is timely for many reasons and raises very important questions in the management of the current rise in HPV-positive patients with oropharyngeal cancer (OPC). The uniqueness of this group within head and neck cancer in terms of favourable...